About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
AF and Heart Failure: What’s the Risk? Is Ablation the Answer?
By
Northwestern Medicine: 8th Annual Cardiovascular Update
FEATURING
Jonathan Piccini
August 14, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
62:41
Boston Scientific
Incorporating Local Impedance Into Your RF Ablation Practice
Feat.
R. Tung,
C. Meyer,
S. Kapa
Related Content
AUTOPLAY
ON
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Fri, Jun 26, 2020
Faculty:
Roderick Tung
,
Boston Scientific
,
David Haines
Boston Scientific
Incorporating Local Impedance Into Your RF Ablation Practice
Mon, Sep 14, 2020
Faculty:
Boston Scientific
,
Roderick Tung
,
Suraj Kapa
,
Christian Meyer
57:44
University of Colorado Department of Medicine
MythBusters: Cardiac Amyloidosis
Feat.
A. Ambardekar
51:47
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Feat.
R. Tung,
D. Haines
13:07
Michelle Kittleson
2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …
28:59
AtriCure
Hybrid Atrial Fibrillation Ablation: Addressing the Persistent and L…
Feat.
F. Yang
04:50
AtriCure
Discussion on Advanced Atrial Fibrillation: What Is It and How To Tr…
22:46
AtriCure
CONVERGE Trial Results: Level 1 Superiority Data of Hybrid AF™ Conve…
Feat.
D. Lurgio
18:36
Texas Heart Institute
Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?
Feat.
M. Razavi
21:36
NYU Langone
Emerging Therapies in Cardiac Amyloidosis
Feat.
M. Hanna
19:30
David DeLurgio
What Does the Convergent Procedure Add to Catheter Ablation of Atria…
19:30
Nasrien Ibrahim
Hot Topics in Heart Failure ACC.22
12:23
American Heart & Vascular Institute
SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Ho…
Feat.
M. Tipton
03:36
AtriCure
Discussion on Advanced Atrial Fibrillation: Why Hybrid AF™ Therapy a…
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2…
Feat.
B. Greenberg
16:12
Courage and Innovation Symposium: Heart Failure & Heart Transplantation
The Future of Heart Transplantation: Spurring Innovation, Saving Mor…
Feat.
V. Jeevanandam
22:40
Nitesh Sood
Hybrid AFib Ablation: Persistent AFib Management in the Current Era
14:44
26th Annual San Diego Heart Failure Symposium
Broadening Indications for the Use of Angiotensin Receptor Neprilysi…
Feat.
C. Yancy
88:01
CCM® Therapy
The Comparison and Advantages of the Use of Device Therapy in Heart …
Feat.
V. Thohan,
G. Tomassoni,
R. Doshi,
F. Abi-Samra,
I. Rao
15:32
10th Annual California Heart Rhythm Symposium
Ablation of Persistent AF – What to Do Beyond PV Isolation?
64:40
CCM® Therapy
CCM® Therapy - Mechanism of Action, Patient Selection and Identifica…
Feat.
A. Kaplan,
H. Saltzman
17:22
Getinge
IABP case study in Advance Heart Failure
Feat.
J. Estep
